Article
Novel Therapeutics in Acute Myeloid Leukemia.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting - 1 Jan 2017
DiNardo Courtney D, Stone Richard M, Medeiros Bruno C
Abstract excerpt
In this review, we focus on three key areas in acute myeloid leukemia (AML) developmental therapeutics: FLT3 inhibitors, IDH inhibitors, and drugs that may be particularly beneficial in secondary AML.
Topics
- Aminopyridines
- Humans
- Isocitrate Dehydrogenase
- Leukemia, Myeloid, Acute
- Molecular Targeted Therapy
- Mutation
- Triazines
- fms-Like Tyrosine Kinase 3